French drugmaker Sanofi (SNY) is looking to expand in emerging markets and will "probably not"...

|By:, SA News Editor

French drugmaker Sanofi (SNY) is looking to expand in emerging markets and will "probably not" be a bidder for Pfizer's (PFE) animal health business, CEO Chris Viehbacher says. Also, after resuming shipments of the rare disease drug Fabrazyme last week, SNY expects to resume supplying European patients with full doses of the drug by "about mid-year." SNY +0.8% premarket.